Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board
December 18, 2018 07:30 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of...
Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights
November 06, 2018 06:56 ET
|
Cellular Biomedicine Group Inc.
Debuted its next 12-18 months’ immuno-oncology clinical development programs for both hematologic malignancies and solid tumors to key opinion leaders, investment and industry executivesLicensed...
Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai
October 25, 2018 08:56 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors
October 03, 2018 07:30 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
CBMG（西比曼生物科技集团）针对中国患者与 CAR-T 细胞治疗领域的全球领导者达成战略许可和合作协议
September 27, 2018 07:42 ET
|
Cellular Biomedicine Group Inc.
与诺华公司的合作内容包括以 4,000 万美元收购 CBMG 的1,458,257 股股票，对其开展股权投资，股票价格为每股 27.43 美元CBMG 将授权诺华公司在全球范围内使用其特定专有技术CBMG 将在中国生产和供应 Kymriah® (tisagenlecleucel） 上海和加利福尼亚州库比蒂诺, Sept. 27, 2018 (GLOBE NEWSWIRE) --...
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
September 24, 2018 08:15 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference
August 28, 2018 09:16 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights
August 08, 2018 07:31 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- China Food and Drug Administration (CFDA) Accepts the Company’s Investigational New Drug (IND) Applications for anti-CD19...
Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland
June 22, 2018 09:00 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia
June 21, 2018 07:30 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...